The Efficacy of Liposomal Bupivacaine in Ultrasound Guided Supraclavicular Nerve Blocks for Hand and Wrist Surgery
1 other identifier
interventional
120
1 country
1
Brief Summary
Patients undergoing hand, wrist, and elbow surgery may experience pain after surgery. The orthopedic surgeon may provide prescription pain medications after surgery to assist with pain control. However, with concern of the opioid epidemic, many patients would rather minimize the use of narcotic pain prescriptions after having surgery. As an alternative, ultrasound guided regional nerve blocks can assist with postoperative pain control. patients consented to this study will be randomized into three groups: 1) will receive an ultrasound guided nerve block with local anesthesia only, 2) will receive an ultrasound guided nerve block with local anesthesia and a steroid dexamethasone, 3) will receive an ultrasound guided nerve block with liposomal bupivacaine. our study team will make phone calls after surgery to the patient to determine how long the block lasted for, and how many opioid pain pills were taken up to 3 days after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedFirst Submitted
Initial submission to the registry
January 28, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 30, 2025
CompletedFirst Posted
Study publicly available on registry
February 4, 2025
CompletedFebruary 6, 2025
January 1, 2025
1.6 years
January 28, 2025
February 3, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Subjective length of duration of block
our study team contacts the patients 4 days after surgery to ask how long their regional nerve block lasted
feedback obtained up until day 3 after surgery
Secondary Outcomes (1)
Number of opioid pills taken until postoperative day 3
feedback until day 3 after surgery
Study Arms (3)
Control Arm: local anesthesia only in ultrasound guided supraclavicular nerve block
NO INTERVENTIONultrasound guided supraclavicular nerve blocks are typically performed with the use of local anesthesia only
Study Arm: local anesthesia with perineural dexamethasone
EXPERIMENTALdexamethasone is a potent steroid that when provided in ultrasound guided nerve blocks can extend the duration of the nerve block.
Study Arm: liposomal bupivacaine
EXPERIMENTALour study team would like to determine how use of liposomal bupivacaine in supraclavicular nerve blocks can lengthen the duration of the nerve block, and how it may affect the number of opioid pills used after surgery up until postoperative day three.
Interventions
our study team wishes to determine effect of liposomal bupivacaine in regional nerve blocks for surgery of the upper extremity (finger, hand, wrist, elbow)
dexamethasone injected in perineural area can extend the regional nerve block
Eligibility Criteria
You may qualify if:
- patients scheduled to undergo finger, hand, wrist, elbow surgery with a hand surgeon at St. Luke's University Hospital in Bethlehem, Pennsylvania
- patients greater than 18 years of age, able to provide written consent for surgery and study
You may not qualify if:
- patients that cannot provide written consent for finger, hand, wrist, elbow surgery
- patients with known allergies to local anesthetics
- patients with severe liver disease
- patients with a condition known as methemoglobinemia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Luke's University Health Network
Bethlehem, Pennsylvania, 18015, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Ng-Pellegrino, MD
St. Luke's Hospital and Health Network, Pennsylvania
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- the patient is blinded to the study arm
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2025
First Posted
February 4, 2025
Study Start
May 1, 2023
Primary Completion
November 30, 2024
Study Completion
January 30, 2025
Last Updated
February 6, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- we will provide deidentified data on patients participating within the start to end dates of patient recruitment. This data will be available to view in anticipated publication to a journal
- Access Criteria
- This information can be available to view after publication to a journal.
we will provide results on our measured outcomes: subjective length of duration of block, number of opioid pills taken by postsurgical day 3. we will provide de-identified information on demographics as well between the control arm and treatment arms